Liposomal Encapsulated Rhodomyrtone: A Novel Antiacne Drug

Table 5

Comparison of minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of topical drugs and liposomal encapsulated rhodomyrtone against Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis ATCC 35984.

Topical drugs	MICs/MBCs (µg/mL)
	Staphylococcus aureus	Staphylococcus epidermidis
	ATCC 25923	ATCC 35984
Azelaic acid (20% w/w)	256/512	64/128
Benzoyl peroxide (2.5% w/w)	>1024	>1024
Clindamycin (1% w/v)	1/64	>1024
Liposomal encapsulated rhodomyrtone	1/4	2/8